Pharmacogenomics (PGx)

Subscribe

We conclude that PGx based on targeted [Oxford Nanopore sequencing] is a valuable tool to advance the implementation of personalised medicine

Deserranno, K. et al. Front. Pharmacol. (2023)

  • Icon displaying a graphic of any length nanopore reads
    Access full-gene, long-read coverage results to unambiguously phase haplotypes for PGx star allele and variant calling
  • Icon displaying a graphic of structural variation
    Call all PGx variants, including small and structural variants, and complex copy number alterations
  • Blue icon showing scale from low to high output
    Achieve high-confidence, comprehensive PGx sequencing at your choice of throughput
Intro

Comprehensively characterise PGx gene variants in a single assay

Pharmacogenomics (PGx) is the study of how genomics influences drug responses with the aim of identifying precise drug treatments for individuals. Genomic variation influences how drugs are absorbed, distributed, and metabolised (pharmacokinetics), as well as how they interact with biological pathways (pharmacodynamics). Furthermore, genetic differences can contribute to adverse drug reactions, such as hypersensitivity and allergic reactions, highlighting the need for personalised drug dosing based on genetics to improve treatment outcomes.

A major challenge of PGx is the complexity and diversity of genomic variations, which cannot be characterised on one platform using traditional methods. Oxford Nanopore Technologies offers a complete PGx solution, enabling comprehensive analysis all PGx variations in a single assay.

Animation of a long fragment of long-stranded DNA